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Identity 
Other names: GLI; Zinc finger protein GLI1 (glioma-
associated oncogene); Oncogene GLI; Glioma-
associated oncogene homolog 1 
HGNC (Hugo): GLI1 
Location: 12q13.2-q13.3 
Location (base pair): Position 56140200-56152312 on 
the chromosome 12 genomic sequence. 
Local order: Telomeric to the ATF1 gene; centromeric 
to the OS-9, SAS and CDK4 genes. 
Note: GLI1 was the first human member of the 
Krüppel zinc finger proteins to be identified, and 
constitutes the archetype of this family of human ge es. 
Other members are GLI2 (2q14) and GLI3 (7p13). 
GLI4/HKR4 (8q24) was misclassified as member of 
the human GLI gene family. 
DNA/RNA 
Description 
12 exons, spans approximately 12 kb of genomic DNA 
in the centromere-to-telomere orientation. The 
translation initiation codon is located to exon 2, and the 
stop codon to exon 12. 
Transcription 
mRNA of 3.6 kb. 
Protein 
Description 
The open reading frame encodes a 1106 amino acid 
protein, with an estimated molecular weight of 
approximately 118 kDa. The protein contains five 
DNA-binding zinc fingers between amino acids 235 
and 393 (encoded by exons 7-10), and a transactivating 
domain constituted by amino acids 1020-1091 
(encoded by exon 12). 
Expression 
GLI proteins function as direct effectors of sonic 
hedgehog-signaling during embryogenesis. GLI1 (also 
GLI2 and GLI3) are therefore likely to be involved in 
the tissue-specific proliferation of the central nervous 
system, the zones of polarizing activity in the 
developing limb, and of the gut. In the adult human, 
GLI1 expression has been demonstrated in the testes, 
myometrium and Fallopian tubes. 
Localisation 
Nuclear. Might be fluctuating between the cytoplasm 
and the nucleus. 
Function 
DNA-binding transcription factor. 
 
 
Genomic organization of the GLI1 gene. 











An abnormal activity of GLI, caused by mutations 
affecting upstream components of the sonic hedgehog-
signaling pathway (sonic hedgehog, patched or 
smoothened) are associated with developmental 
disorders. 
Somatic 




Rearrangement and fusion of the GLI1 gene. 
Disease 
Pericytoma with t(7;12) 
Prognosis 




ACTB-GLI1 fusion gene. The breakpoints reported so 
far have been located to introns 1, 2 or 3 within the
ACTB gene, and to introns 5 or 6 or to exon 7 within 
the GLI1 gene. Reciprocal GLI1-ACTB gene fusions 
have also been detected. The breakpoints have been 
located to introns 5 or 7 within the GLI1 gene, and to 
intron 3 of the ACTB gene. 
 
Representative G-banded partial karyotype of the 
t(7;12)(p22;q13). 
Abnormal protein 
The ACTB-GLI1 fusion protein contains the N-
terminal of ACTB and the C-terminal of GLI1, 
including the DNA-binding zinc finger motifs (encode  
by exons 7-10) and transactivating motifs (exon 12).
Oncogenesis 
It is suggested that the strong ACTB promoter causes  
an overexpression of GLI1 sequences important for 
transcriptional activation of downstream target genes, 
akin to the oncogenic mechanisms of the COL1A1-
PDGFB fusion gene detected in dermatofibrosarcoma 
protuberans. 
Note 
Amplification of the GLI1 gene. 
Disease 
Glioma, B-cell lymphoma, sarcoma 
Prognosis 
Depends on tumor type. 
Oncogenesis 
Overexpression of GLI1 sequences. Might be of 
prognostic importance. 
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